Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$3.3700
-0.1600 ( -3.16% ) 596.3K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$3.3700

Previous close


$3.5300

Volume


596.3K

Market cap


$227.77M

Day range


$3.3150 - $3.5280

52 week range


$2.7000 - $19.0500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 16 Jun 14, 2024
4 Insider transactions 1 Jun 13, 2024
4/a Other 1 Jun 05, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
8-k 8K-related 12 May 31, 2024
4 Insider transactions 1 May 30, 2024

Latest News